focused on ensuring that growing
companies – no matter where
they are located around the globe
–
are connected to the
Massachusetts supercluster.
We are next on the global stage
this fall, when the BioPharm
America conference returns to
Boston September 19-21. The
conference, organized by the EBD
Group and hosted by MassBio, is
an opportunity to connect with
the most active companies in the
business development and
licensing arena, including
Actelion, Alkermes, Alexion,
Amgen, AstraZeneca, Atlas
Ventures, Baxter, Biogen Idec,
Bristol-Myers Squibb, Celgene,
CMEA Capital, Epizyme,
Visit us online at
Robert K. Coughlin
Mass BIO
Leading the next lif
